Ryan T. Sullivan's most recent trade in Intercept Pharmaceuticals Inc was a trade of 493 Common Stock done at an average price of $37.9 . Disclosure was reported to the exchange on Nov. 13, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc | Ryan T. Sullivan | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.87 per share. | 13 Nov 2020 | 493 | 24,708 (0%) | 0% | 37.9 | 18,670 | Common Stock |